Let’s Talk About CRISPR Therapeutics AG (NASDAQ: CRSP)’s Outlook
In the last trading session, 1.48 million CRISPR Therapeutics AG (NASDAQ:CRSP) shares changed hands as the company’s beta touched 1.76. With the company’s per share
In the last trading session, 1.48 million CRISPR Therapeutics AG (NASDAQ:CRSP) shares changed hands as the company’s beta touched 1.76. With the company’s per share
In last trading session, CRISPR Therapeutics AG (NASDAQ:CRSP) saw 1.4 million shares changing hands with its beta currently measuring 1.75. Company’s recent per share price
In today’s recent session, 0.73 million shares of the CRISPR Therapeutics AG (NASDAQ:CRSP) have been traded, and its beta is 1.81. Most recently the company’s
In the last trading session, 1.26 million CRISPR Therapeutics AG (NASDAQ:CRSP) shares changed hands as the company’s beta touched 1.87. With the company’s per share
CRISPR Therapeutics AG (NASDAQ:CRSP) has a beta value of 1.71 and has seen 0.52 million shares traded in the recent trading session. The company, currently
CRISPR Therapeutics AG (NASDAQ: CRSP) expects to submit an application for gene therapy approval by the end of the year. This medicine already earned good
© 2024, Powered by Smart TechOne